.png)
Long COVID Biomarkers
The Long COVID Foundation (LCF) and Long Covid Action Project (LCAP) are excited to partake in a fundraiser in order to help validate a Long COVID Biomarkers Test capable of FDA approval for clinical use and trials. With help from our grassroots activism, researchers in Belgium will be able to use donations gathered by this campaign to externally validate a set of universal Long COVID biomarkers for immune changes and SARS-CoV-2 viral persistence.
​
This research could be monumental for those of us who’ve developed Long COVID and have waited years for biomarkers. Now until July 31, 2024, $15,000 has been pledged in matching dollar for dollar funds, so please donate, support, and/or share this vital initiative now! All United States Donations are tax deductible.
Background
In 2024, Dr. Johan Van Weyenbergh, and his team of researchers, published a groundbreaking paper outlining results of a blood test that could identify Long COVID with 91.7% certainty using transcriptomic testing equipment that is widely available and can be FDA approved. The current test used in the study processes 800 genes to measure RNA viral load of SARS-CoV-2 and immune RNA at a cost that is roughly $400-$600 per sample. Your donations to this campaign will fund the second round of testing to validate the results discovered in Dr. Van Weyenbergh's research. This validation round will bring the research closer to FDA approval by funding more than 100 additional tests from samples in the USA, UK, and France to be published in a new paper.
If our grassroots fundraising is successful, Dr. Van Weyenbergh believes the validated biomarkers could be limited to a test of 50 genes, reducing the total cost of each sample in the future to $50-$100. This would radically change the ability of the NIH to run affordable validated biomarker tests in ongoing RECOVER trials and independent studies, as well as open access to more affordable Long COVID tests in clinical settings.
Organizational Statement
LCF and LCAP believe this campaign solidifies how essential grassroots activism is to Long COVID research. Once we come together and meet our fundraising goal the community’s work will help inform trials to develop treatments to save lives in the future. If our efforts are successful, and Dr. Weyenbergh’s research is validated, we will call on the FDA to recognize the first qualified biomarkers for Long COVID. Our follow-up actions will work with the FDA to establish an approved Long COVID Test available for public use. The Long COVID Biomarkers Campaign is an essential investment towards the development of critical and effective treatments. Our heartfelt thanks to all of you for contributing in your own way to this campaign.
For more about this campaign you can check out our latest updates below or on LongCovidBiomarkers.com.
For press inquiries please contact:
Joshua Pribanic (LCAP) at p: (419)-202-8503 e: joshua[at]publicheraldstudios[dot]com
Devin Russell (Long COVID Foundation) at p: (631)-296-2221 e: info[at]longcovidfoundation[dot]org.
Long Covid Action Project (LCAP) is a united, diverse force of non-partisan individuals taking action to end the Long COVID crisis. We demand urgent treatment and support for the Long COVID community by mobilizing public awareness and driving government accountability.
Long COVID Foundation’s mission is to bring awareness to the public regarding Long COVID & other pandemic related issues, advocate for better testing, trials, & treatments for Long COVID, and take action in assisting COVID Long Haulers, and others affected by the pandemic. Long COVID Foundation Inc. is tax exempt under Internal Revenue Code section 501(c)(3). EIN 933724191.
*** This fundraising effort is now complete. Dr. Johan Van Weyenbergh has all the funds needed to conduct his study, with his team. You can see out press release on the Initiatives Page (under Major Initiative) for more information.